Literature DB >> 28082234

Increased systemic and epidermal levels of IL-17A and IL-1β promotes progression of non-segmental vitiligo.

Supriya Bhardwaj1, Seema Rani2, Niharika Srivastava1, Ravinder Kumar2, Davinder Parsad3.   

Abstract

BACKGROUND: Non-segmental vitiligo (NSV) results from autoimmune destruction of melanocytes. The altered levels of various cytokines have been proposed in the pathogenesis of vitiligo. However, the exact immune mechanisms have not yet been fully elucidated.
OBJECTIVES: To investigate the role of epidermal and systemic cytokines in active and stable NSV patients.
METHODS: Serum levels of inflammatory cytokines were checked in 42 active and 30 stable NSV patients with 30 controls. The lesional, perilesional and normal skin sections were subjected to H&E staining. The mRNA expression of inflammatory cytokines and their respective receptors were assessed by quantitative PCR in lesional skin of both active and stable NSV skin. The MITF and IL-17A were immunolocalized in lesional, perilesional and normal skin tissue.
RESULTS: Significant increase in the expression of inflammatory cytokines, IL-17A, IL-1β and TGF-β was observed in active patients, whereas no change was observed in stable patients. A marked reduction in epidermal thickness was observed in lesional skin sections. Significant increase in IL-17A and significant decrease in microphthalmia associated transcription factor (MITF) expression was observed in lesional and perilesional skin sections. Moreover, qPCR analysis showed significant alterations in the mRNA levels of IL-17A, IL-1β, IFN-γ, TGF-β and their respective receptors in active and stable vitiligo patient samples.
CONCLUSION: Increased levels of IL-17A and IL-1β cytokines and decreased expression of MITF suggested a possible role of these cytokines in dysregulation of melanocytic activity in the lesional skin and hence might be responsible for the progression of active vitiligo. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Depigmentation; Inflammatory cytokines; Melanocytes; Non-segmental vitiligo

Mesh:

Substances:

Year:  2017        PMID: 28082234     DOI: 10.1016/j.cyto.2016.12.014

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  13 in total

1.  Association of rs4711998 of IL-17A, rs2275913 of IL-17A and rs763780 IL-17F gene polymorphisms with non-segmental vitiligo in a Mexican population.

Authors:  Natalia Aranza Zapata-Salazar; David Emmanuel Kubelis-Lopez; Mauricio Andres Salinas-Santander; Celia Nohemi Sanchez-Dominguez; Ana Cecilia Xolalpa-Rosales; Marely Eugenia Gomez-Galindo; Jorge Ocampo-Candiani
Journal:  Arch Dermatol Res       Date:  2022-08-12       Impact factor: 3.033

2.  Dendritic cells sub-sets are associated with inflammatory cytokine production in progressive vitiligo disease.

Authors:  Niharika Srivastava; Anuradha Bishnoi; Davinder Parsad; Muthu Sendhil Kumaran; Keshavamurthy Vinay; Sarika Gupta
Journal:  Arch Dermatol Res       Date:  2021-01-05       Impact factor: 3.017

Review 3.  Clinical and Molecular Aspects of Vitiligo Treatments.

Authors:  Anuradha Bishnoi; Davinder Parsad
Journal:  Int J Mol Sci       Date:  2018-05-18       Impact factor: 5.923

Review 4.  Inflammasomes in Common Immune-Related Skin Diseases.

Authors:  Lili Tang; Fusheng Zhou
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

5.  Therapeutic effects of iNOS inhibition against vitiligo in an animal model.

Authors:  Hamid Mansourpour; Katayoun Ziari; Sahar Kalantar Motamedi; Amin Hassan Poor
Journal:  Eur J Transl Myol       Date:  2019-08-06

6.  Immunophenotype of circulatory T-helper cells in patients with non-segmental vitiligo.

Authors:  Rajendiran Kalaiselvi; Medha Rajappa; Laxmisha Chandrasekhar; Devinder M Thappa; Priyadarssini Munisamy
Journal:  Postepy Dermatol Alergol       Date:  2019-08-30       Impact factor: 1.837

7.  Reciprocal regulation of interleukin-17A and interleukin-22 secretion through aryl hydrocarbon receptor activation in CD4+ T cells of patients with vitiligo.

Authors:  Baoyi Liu; Yongyi Xie; Xingyu Mei; Yue Sun; Weimin Shi; Zhouwei Wu
Journal:  Exp Ther Med       Date:  2020-12-17       Impact factor: 2.447

8.  Increased Circulatory Interleukin-17A Levels in Patients with Progressive and Leukotrichial Vitiligo.

Authors:  Thai Van Thanh Le; Huy Ngoc Phan; Tran Ngoc Dang; Le Duy Pham
Journal:  Dermatol Res Pract       Date:  2021-04-21

9.  Critical role of metabotropic glutamate receptor 4 in bone marrow-derived dendritic cells in the Th17 cell differentiation and the melanogenesis of B16 cells.

Authors:  Guangming Zhao; Wenhui Zhou; Ying Liu; Yupeng Wang; Zhou Li; Zhiqi Song
Journal:  Braz J Med Biol Res       Date:  2020-04-06       Impact factor: 2.590

10.  Urinary metabolomic investigations in vitiligo patients.

Authors:  Wei Liu; Xiao-Yan Liu; Yue-Tong Qian; Dong-Dong Zhou; Jia-Wei Liu; Tian Chen; Wei Sun; Dong-Lai Ma
Journal:  Sci Rep       Date:  2020-10-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.